State Street’s Allena Pharmaceuticals ALNA Stock Holding History

State Street’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-205,058	Closed	-$39K	–	4985
2022 Q2	$39K	Hold	205,058	–	–	﹤0.01%	4777
2022 Q1	$47K	Hold	205,058	–	–	﹤0.01%	4806
2021 Q4	$121K	Hold	205,058	–	–	﹤0.01%	4529
2021 Q3	$185K	Buy	205,058 +170,800	+499%	+$167K	﹤0.01%	4380
2021 Q2	$45K	Buy	+34,258	New	+$41.5K	﹤0.01%	4436
2019 Q2	–	Sell	-181,520	Closed	-$1.27M	–	3865
2019 Q1	$1.27M	Sell	181,520 -3,787	-2%	-$27.5K	﹤0.01%	3290
2018 Q4	$1.01M	Buy	185,307 +387	+0.2%	+$3.34K	﹤0.01%	3326
2018 Q3	$1.99M	Buy	184,920 +26,881	+17%	+$295K	﹤0.01%	3244
2018 Q2	$2.06M	Buy	158,039 +132,415	+517%	+$1.91M	﹤0.01%	3246
2018 Q1	$282K	Buy	+25,624	New	+$214K	﹤0.01%	3508

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street's ALNA Position: Q3 2022 in Review

State Street sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 205,058 shares — an estimated $39K sold.

State Street first reported a position in ALNA in Q1 2018 and held it in 10 quarters. The position peaked at $2.06M in Q2 2018. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

State Street reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
State Street sold 205,058 Allena Pharmaceuticals shares in Q3 2022, an estimated $39K.
State Street first reported a position in Allena Pharmaceuticals in Q1 2018 and held it in 10 quarters.
State Street's Allena Pharmaceuticals position peaked at $2.06M in Q2 2018.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.